Prostate Specific Antigen Kinetics in the Management of Prostate Cancer-Reference-Cited by-同舟云学术

Prostate Specific Antigen Kinetics in the Management of Prostate Cancer

Published:2008-03 Issue:3 Volume:179 Page:821-826
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Sengupta Shomik¹,Amling Christopher²,D’Amico Anthony V.³,Blute Michael L.¹

Affiliation:

1. Department of Urology, Mayo Clinic, Rochester, Minnesota

2. Department of Urology, University of Alabama, Birmingham, Alabama

3. Department of Radiation Oncology, Brigham and Women’s Hospital, and the Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference50 articles.

1. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease;Carter;JAMA,1992

2. Observations on the doubling time of prostate cancer;Schmid;Cancer,1993

3. Simple graphic method for estimation of prostate-specific antigen doubling time;Sengupta;Urology,2006

4. Variations in PSA doubling time in patients with prostate cancer on “watchful waiting”: value of short-term PSADT determinations;Ross;Urology,2004

5. Early outcomes of active surveillance for localized prostate cancer;Hardie;BJU Int,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically supported causality between benign prostate hyperplasia and urinary bladder neoplasms: A mendelian randomization study;Frontiers in Genetics;2022-11-17

2. Neoplasms of the Prostate;Holland‐Frei Cancer Medicine;2022-10-21

3. Neoplasms of the Prostate;Holland-Frei Cancer Medicine;2017-02-26

4. Serum marker %[-2]proPSA and the Prostate Health Index improve diagnostic accuracy for clinically relevant prostate cancer;BJU International;2015-12-10

5. Precision treatment for cancer: Role of prognostic and predictive markers;Critical Reviews in Clinical Laboratory Sciences;2014-01-16